| Product Name | Influenza H1N1 combo rapid assay kit |
| Catalog No. | IP-00195 |
| Description | The influenza H1N1 combo rapid assay kit is a diagnostic tool used to quickly detect the presence of influenza H1N1 in humans. |
| Sample Type | Swab |
| Application | This product can be used for rapid in vitro screening of influenza H1N1. |
| Operating Temperature | Store at 4-30°C. |
| Transportation Condition | Transportation at room temperature. |
The Influenza H1N1 Combo Rapid Assay Kit is also known as the Influenza A H1N1 Rapid Detection Kit. It is a highly specialized diagnostic tool designed to detect the presence of influenza A H1N1 virus in respiratory specimens. Influenza H1N1, commonly referred to as swine flu, emerged as a global pandemic in 2009 and continues to be a significant public health concern. This virus spreads rapidly and can cause severe respiratory illness, making early detection crucial for effective treatment and containment of outbreaks.
The kit is based on the principle of immunochromatography, which allows for the rapid detection of viral antigens in a sample. It is designed to provide results within a short period, typically 15 minutes, making it ideal for point-of-care testing in various settings. This quick turnaround time is essential for managing influenza outbreaks, especially in high-risk populations such as the elderly, young children, and individuals with compromised immune systems.
·Simultaneous Testing: Can detect both influenza A and H1N1 subtypes in a single test, offering comprehensive screening.
·High Sensitivity and Specificity: Demonstrates high accuracy in detecting viral antigens, ensuring reliable results.
·User-Friendly: Simple to use, requiring minimal training, making it suitable for healthcare professionals and non-laboratory settings.
·Convenient Sampling: Utilizes nasal or throat swabs, minimizing patient discomfort and maximizing sample collection efficiency.
·No Equipment Required: Can be performed without specialized laboratory equipment, enhancing its portability and accessibility.
·Time-Efficient: Reduces the time required for diagnosis, allowing for prompt treatment and management of infected individuals.
·Cost-Effective: Eliminates the need for expensive laboratory infrastructure and extensive training, making it accessible to a wide range of healthcare providers.
·Versatile Application: Suitable for use in clinics, hospitals, schools, and other settings, supporting rapid response to outbreaks.
·Reduces Misdiagnosis: By accurately distinguishing between influenza A and H1N1, it helps in avoiding unnecessary antibiotic use and targeted treatment.
·Supports Public Health: Facilitates large-scale screening efforts, aiding in the monitoring and control of influenza outbreaks.
For in vitro diagnostic use.
|
There is no product in your cart. |
Copyright © 2025 Alta DiagenoTech. All rights reserved.
